A total of eight clinical abstracts for the investigational agent empagliflozin will be presented. Empagliflozin is a sodium glucose co-transporter 2 (SGLT2) inhibitor being investigated for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results